SEARCH

SEARCH BY CITATION

References

  • 1
    Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut 1999; 44: 7315.
  • 2
    Farrell GC. Drug-induced hepatic injury. J Gastroenterol Hepatol 1997; 12: S24250.
  • 3
    Schenker S, Bay M. Drug disposition and hepatotoxicity in the elderly. J Clin Gastroenterol 1994; 18: 232.
  • 4
    Lewis JH. Drug-induced liver disease. Med Clin N Am 2000; 84: 1275311.
  • 5
    Dossing M, Sonne J. Drug-induced hepatic disorders. Incidence, Management and avoidance. Drug Saf 1993; 9: 4419.
  • 6
    Hussaini SH, O’Brien CS, Despott EJ, Dalton HR. Antibiotic therapy – a major cause of drug induced jaundice in southwest England. Euro J Gastro Hepatol 2007; 19: 1520.
  • 7
    Beninchou C, Danan G, Benhamou JP, et al. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990; 1: 2726.
  • 8
    Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol 2003; 13: 14554.
  • 9
    Hamid SS, Atiq M, Shehzad F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002; 36: 4748.
  • 10
    Ramachandran J, Eapen C, Kang G, et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastrohepatol 2004; 19: 1348.
  • 11
    Levine DF, Bendall RP, Teo CG. Hepatitis E acquired in the UK. Gut 2000; 47: 740.
  • 12
    McCrudden R, O’Connell S, Farrant T, et al. Sporadic acute hepatitis E in the UK: an under diagnosed phenomenon? Gut 2000; 46: 7323.
  • 13
    Banks M, Bendall R, Grierson S, Heath G, Mitchell J, Dalton HR. Human and porcine hepatitis E virus strains, UK. J Emerging Infectious Disease 2004; 10: 9535.
  • 14
    Ijaz S, Arnold E, Banks M, et al. Non-travel-associated hepatitis E: demographic, clinical and molecular epidemiological characteristics. Journal Infectious Diseases 2005; 192: 116672.
  • 15
    Dalton HR, Thurairajah PH, Fellows HJ, et al. Autochthonous hepatitis E in southwest England. J Viral Hepatitis 2007; 14: 3049.
  • 16
    Miuzo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis E in Japan. J Clin Microbiol 2002; 40: 320918.
  • 17
    Widdowson M-A, Jaspers WJM, Van Der Poel WHM, et al. Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in the Netherlands. Clin Infect Dis 2003; 36: 2933.
  • 18
    Mansuy JM, Peron JM, Abravanel F, et al. Hepatitis E in the South west of France in individuals who have never visited an endemic area. J Med Virol 2004; 74: 41924.
  • 19
    Schlauder GG, Desai SM, Zanetti AR, Tassopoulos NC, Mushahwar IK. Novel hepatitis E virus (HEV) isolated from Europe: evidence for additional genotypes of HEV. J Med Virol 1999; 57: 24351.
  • 20
    Dalton HR, Fellows HJ, Gane E, et al. , Garkevenko. Hepatitis E in New Zealand. J Gastro Hepatol (in press).
  • 21
    Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369: 1260.
  • 22
    Lewis H, Morgan D, Ijaz S, Boxall E. Indigenous hepatitis E in England and Wales. BMJ 2006; 332: 150910.
  • 23
    Dalton HR, Stableforth W, Cole E, et al. HEV IgG seroprevalence in SW England. Gut 2007; 56: A124.
  • 24
    Mitchell J, Hussaini SH, McGovern DPM, Farrow R, Maskell GM, Dalton HR. The jaundice hotline for the rapid assessment of patients with jaundice. BMJ 2002; 325: 2135.
  • 25
    Danan G, Benichou C. Causality assessment of adverse reactions to drugs –I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 132330.
  • 26
    Wang Y, Levine D, Bendall RP, et al. Partial sequence analysis of indigenous hepatitis E virus isolated in the UK. J Med Virol 2001; 65: 7069.
  • 27
    Buti M, Jardi R, Cotrina M, et al. Hepatitis E virus infection in acute hepatitis in Spain. J Virol Methods 1995; 55: 4954.
  • 28
    Tanaka E, Takeda N, Li TC, et al. Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay. J Gastroenterology 2001; 36: 31721.
  • 29
    Li T, Zhang J, Shinzawa H, et al. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J Med Virol 2000; 62: 32733.
  • 30
    Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40: 11722.
  • 31
    Thomas DL, Yarbrough PO, Vlahov D, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997; 35: 12447.